Stocks
Immunome (IMNM) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -9.72 | -12.3 | -24.7 | -36.3 | -108.8 | -236.7 | ||
| Changes by years, y/y, % | +35% | +26% | +101% | +47% | +200% | +72.2% | |||
Immunome. EBITDA US GAAP, bln rub
Immunome. EBITDA US GAAP, changes, %
Immunome. EBITDA US GAAP, sum by quarters, bln rub
Immunome (IMNM) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -4.47 | -5.62 | -4.63 | -94.4 | -132.0 | -236.7 | |
| Changes by years, y/y, % | -61% | -36% | -45% | +1 154% | +2 853% | |||
| Changes by quarters, q/q, % | -41% | +26% | -18% | +1 937% | +40% | |||
